Does UPADACITINIB Cause Coronary artery occlusion? 86 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Coronary artery occlusion have been filed in association with UPADACITINIB (Rinvoq). This represents 0.1% of all adverse event reports for UPADACITINIB.
86
Reports of Coronary artery occlusion with UPADACITINIB
0.1%
of all UPADACITINIB reports
1
Deaths
32
Hospitalizations
How Dangerous Is Coronary artery occlusion From UPADACITINIB?
Of the 86 reports, 1 (1.2%) resulted in death, 32 (37.2%) required hospitalization.
Is Coronary artery occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Coronary artery occlusion?
ADALIMUMAB (1,392)
TICAGRELOR (370)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296)
ROSUVASTATIN (283)
METOPROLOL (230)
SACUBITRIL\VALSARTAN (204)
ASPIRIN (190)
RISANKIZUMAB-RZAA (181)
EVOLOCUMAB (162)
CLOPIDOGREL BISULFATE (155)
Which UPADACITINIB Alternatives Have Lower Coronary artery occlusion Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL